Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Regan Theiler)
Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Regan Theiler)
批准号:
10195445
负责人:
Claudia F. Lucchinetti
金额:
$24.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-18 至 2022-06-30
关键词:
Accident and Emergency departmentAcuteAddressAmerican College of Obstetricians and GynecologistsAreaBirthBirthing CentersCardiovascular DiseasesCardiovascular systemCaringCategoriesCessation of lifeCharacteristicsClinicClinical SciencesColorCommunicationCommunitiesCommunity Health SystemsConsultationsCountryDatabasesDeveloped CountriesDiscipline of obstetricsDiseaseEffectivenessEmergency SituationEtiologyEventFacility AccessesFamily PracticeFrightFutureGeographyGoalsHealth PersonnelHealth care facilityHealth systemHemorrhageHospitalsIncidenceIndigenousIndividualInfectionInfrastructureInterventionLeadershipLeftLifeLinkMaternal MortalityMedicalMedical emergencyMidwestern United StatesMinorityMonitorMothersNurse MidwivesPatientsPerinatalPharmaceutical PreparationsPhysiciansPopulationPostpartum PeriodPregnancyPregnancy OutcomePregnant WomenProviderResearch PersonnelResourcesRisk FactorsRuralRural HealthRural HospitalsSafetyServicesSiteStandardizationSurgeonSystemTechniquesTelemedicineTestingTimeTrainingTranslational ResearchTraumaTravelUnited StatesWomanWorkadvanced maternal ageadverse maternal outcomesantenatalbiomedical referral centercare costscare providersclinical centercostcritical access hospitalevidence baseexpectationhealth care deliveryimprovedinnovationintrapartummaternal conditionmaternal health carematernal morbiditymedical specialtiesmodifiable risknovelobstetric carepreventprogramsresponserural arearural underservedsafety and feasibilitysafety studysevere maternal morbiditysocial health determinantssymposiumtrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Background: Startling increases in the rate of maternal mortality in the United States over recent decades put
the country at the bottom of industrialized nations when it comes to provision of safe maternity care. Some
underlying risk factors have been identified, including a disproportionate burden of maternal mortality among
women of color, women of advanced maternal age, and women living in underserved areas. The shortage of
both maternity units and Ob/Gyn physicians in rural areas has left many areas without any maternity care
providers at all. Because of the multifactorial etiology of the problem, programs seeking to reverse the trend of
increasing maternal mortality must address both individual and systemic risk factors associated with adverse
maternal outcomes.
Objective: The objective of this project is to test the feasibility and safety of a synchronous, remote
telemedicine Obstetrics program serving emergency departments and labor and delivery units at small
hospitals in the Midwestern United States.
Approach: Acute teleOB programs will be implemented at 20 emergency departments and 10 labor and
delivery units in the Mayo Clinic Health System, which serves WI, MN, and IA. Using a real-time HD
audio/video interface, TeleOB consultants at the level IV maternity unit will guide non-obstetricians through the
necessary steps to stabilize patients presenting with obstetric emergencies including hemorrhage, infection,
trauma, and cardiovascular events. Because of the low incidence of maternal mortality, severe maternal
morbidity will be used as a surrogate “near miss” marker of adverse maternal outcomes. In parallel with service
activation, a comprehensive database of births in the Health System (>10,000 per year) will be built to allow
comparison of rates and categories of severe maternal morbidity before and after implementation of the
TeleOB consultation service. The database will also be used to associate adverse maternal outcomes with
medical and social determinants of health, with the goal of identifying modifiable risk factors for maternal
morbidity and mortality that are most relevant for each community. Community advisory boards will be
engaged to plan service implementation and to disseminate any community-specific findings from the study.
Impact: If the TeleOB service demonstrates effectiveness in helping critical access facilities and other small
hospitals to stabilize patients presenting with obstetric emergencies, the program will be disseminated to other
underserved regions and offered to additional health systems. The scalability of the intervention makes it
attractive as a means to reduce geographic inequities and give all women in the U.S. access to high quality
emergency obstetric care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mayo Clinic Center for clinical and Translational Science (CCaTS)
-
批准号:10206302
-
项目类别:
-
资助金额:$524.35万
-
财政年份:2017
-
负责人:Claudia F. Lucchinetti
-
依托单位:
Mayo Clinic Center for clinical and Translational Science (CCaTS)
-
批准号:9981496
-
项目类别:
-
资助金额:$454.48万
-
财政年份:2017
-
负责人:Claudia F. Lucchinetti
-
依托单位:
Genetic Determinants of Pathologic Heterogeneity in MS
-
批准号:7099742
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2006
-
负责人:Claudia F. Lucchinetti
-
依托单位:
Mechanisms of Multiple Sclerosis Tissue Pathology
-
批准号:8259696
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2006
-
负责人:Claudia F. Lucchinetti
-
依托单位:
Mechanisms of Multiple Sclerosis Tissue Pathology
-
批准号:8065972
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2006
-
负责人:Claudia F. Lucchinetti
-
依托单位:
Mechanisms of Multiple Sclerosis Tissue Pathology
-
批准号:7883294
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2006
-
负责人:Claudia F. Lucchinetti
-
依托单位:
Genetic Determinants of Pathologic Heterogeneity in MS
-
批准号:7232273
-
项目类别:
-
资助金额:$32.33万
-
财政年份:2006
-
负责人:Claudia F. Lucchinetti
-
依托单位:
Genetic Determinants of Pathologic Heterogeneity in MS
-
批准号:7418624
-
项目类别:
-
资助金额:$32.33万
-
财政年份:2006
-
负责人:Claudia F. Lucchinetti
-
依托单位:
THE CLINICO-PATHOLOGICAL CORRELATES OF THE MULTIPLE SCLEROSIS LESION
-
批准号:7206081
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2005
-
负责人:Claudia F. Lucchinetti
-
依托单位:
The Clinico-Pathological Correlates of the MS Lesion
-
批准号:7042277
-
项目类别:
-
资助金额:$0.81万
-
财政年份:2003
-
负责人:Claudia F. Lucchinetti
-
依托单位:
海外基金